Tomas Cihlar
Gilead Sciences
333 Lakeside Drive
Foster City
California 94404
USA
Name/email consistency: high
- Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors. Cihlar, T., Birkus, G., Greenwalt, D.E., Hitchcock, M.J. Antiviral Res. (2002)
- Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1. Cihlar, T., Ho, E.S. Anal. Biochem. (2000)
- The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Cihlar, T., Lin, D.C., Pritchard, J.B., Fuller, M.D., Mendel, D.B., Sweet, D.H. Mol. Pharmacol. (1999)
- Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments. Cihlar, T., Fuller, M.D., Cherrington, J.M. J. Virol. (1998)
- A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture. Cihlar, T., Fuller, M.D., Mulato, A.S., Cherrington, J.M. Virology (1998)
- Expression of the catalytic subunit (UL54) and the accessory protein (UL44) of human cytomegalovirus DNA polymerase in a coupled in vitro transcription/translation system. Cihlar, T., Fuller, M.D., Cherrington, J.M. Protein Expr. Purif. (1997)
